Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting antiretroviral drug resistance from the latest or the cumulative genotype.

Antiviral therapy - 1 Jan 2011

Garcia Federico, Alvarez Marta, Fox Zoe, Garcia-Diaz Ana, Guillot Vicente, Johnson Margaret, Chueca Natalia, Phillips Andrew, Hernández-Quero José, Geretti Anna Maria

Abstract excerpt

BACKGROUND: This study evaluates the added benefit when estimating antiretroviral drug resistance of combining all available resistance test results in a cumulative genotype relative to using the latest genotype alone. METHODS: The prevalence of resistance and genotypic sensitivity scores (GSS) predicted by the latest and the cumulative genotype, together with virological outcomes after the latest genotype, were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Predictive Value of Tests

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 21555820
DOI: 10.3851/IMP1753

Genes

GSS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting antiretroviral drug resistance from the latest or the cumulative genotype.PMID 21555820Read ↗

HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures.Semantic proximity Read ↗

Historical resistance profile helps to predict salvage failure.Semantic proximity Read ↗

An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.Semantic proximity Read ↗

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.Semantic proximity Read ↗

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes.Semantic proximity Read ↗

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.Semantic proximity Read ↗

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir.Semantic proximity Read ↗

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance TestingSemantic proximity Read ↗

Predictive value of HIV-1 genotypic resistance test interpretation algorithms.Semantic proximity Read ↗

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.Semantic proximity Read ↗

Decoding HIV resistance: from genotype to therapy.Semantic proximity Read ↗

Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.